Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil pretreatment to reduce sufentanil-induced cough during induction of general anesthesia
ChiCTR2500098291Phase 4Not yet recruiting
- Sponsor
- Air Force Medical Center
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil in cough (2 arms), sponsored by Air Force Medical Center. Primary endpoint: Severity of cough. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
remifentanil
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR2500098291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098291.